The NOX1/4 inhibitor GKT136901 as selective and direct scavenger of peroxynitrite


Dateien zu dieser Ressource

Prüfsumme: MD5:9dc079d1eecf490132afcd3278ec8d59

SCHILDKNECHT, Stefan, Annemarie WEBER, Hanne GERDING, Regina PAPE, Marta ROBOTTA, Malte DRESCHER, Andreas MARQUARDT, Andreas DAIBER, Boris FERGER, Marcel LEIST, 2013. The NOX1/4 inhibitor GKT136901 as selective and direct scavenger of peroxynitrite. In: Current Medicinal Chemistry. 21(3), pp. 365-376. ISSN 0929-8673. eISSN 1875-533X. Available under: doi: 10.2174/09298673113209990179

@article{Schildknecht2013NOX14-27192, title={The NOX1/4 inhibitor GKT136901 as selective and direct scavenger of peroxynitrite}, year={2013}, doi={10.2174/09298673113209990179}, number={3}, volume={21}, issn={0929-8673}, journal={Current Medicinal Chemistry}, pages={365--376}, author={Schildknecht, Stefan and Weber, Annemarie and Gerding, Hanne and Pape, Regina and Robotta, Marta and Drescher, Malte and Marquardt, Andreas and Daiber, Andreas and Ferger, Boris and Leist, Marcel} }

2013 NADPH oxidases (NOX), catalyzing the reduction of molecular oxygen to form the superoxide radical anion (<sup>•</sup>O<sub>2</sub> <sup>-</sup>) and hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>), are involved in several pathological conditions, such as stroke, diabetes, atherosclerosis, but also in chronic neurodegenerative diseases such as Parkinson's disease, Alzheimer's disease, or multiple sclerosis. GKT136901 is a novel NOX-1/4 inhibitor with potential application in the areas of diabetic nephropathy, stroke, or neurodegeneration. In the present study, we investigated additional pharmacological activities of the compound with respect to direct free radical scavenging. GKT136901 did not interact with nitric oxide (<sup>•</sup>NO), <sup>•</sup>O<sub>2</sub> <sup>-</sup>, or hydroxyl radicals (<sup>•</sup>OH), but it acted as selective scavenger of peroxynitrite (PON) already in the submicromolar concentration range. Alpha synuclein (ASYN) is a protein involved in the pathogenesis of Parkinson's disease and a known target for PON-dependent tyrosine nitration. Submicromolar concentrations of GKT136901 prevented tyrosine nitration and di-tyrosine-dependent dimer formation of ASYN by PON as indicated by Western blot and mass spectrometric analysis. GKT136901 itself was degraded when exposed to PON. In a human neuronal cell model, GKT136901 prevented both the depletion of reduced intracellular glutathione, and the degeneration of neurites when present during PON treatment of the cells. When GKT136901 was applied after PON treatment, no protective effect was observed, thus excluding an impact of GKT136901 on cellular death/survival pathways. In summary, selective scavenging of PON is an additional pharmacological property of the NOX-1/4 inhibitor GKT136901, and this may add to the efficiency of the drug in several disease models. Weber, Annemarie Leist, Marcel Leist, Marcel Ferger, Boris Robotta, Marta The NOX1/4 inhibitor GKT136901 as selective and direct scavenger of peroxynitrite Weber, Annemarie Schildknecht, Stefan 2014-03-28T13:11:10Z 2014-03-28T13:11:10Z Marquardt, Andreas Ferger, Boris Current Medicinal Chemistry ; 21 (2014), 3. - S. 365-376 Daiber, Andreas Drescher, Malte Gerding, Hanne Pape, Regina Schildknecht, Stefan Gerding, Hanne terms-of-use eng Daiber, Andreas Drescher, Malte Pape, Regina Marquardt, Andreas Robotta, Marta

Dateiabrufe seit 01.10.2014 (Informationen über die Zugriffsstatistik)

Schildknecht_271294.pdf 251

Das Dokument erscheint in:

KOPS Suche


Mein Benutzerkonto